Company Filing History:
Years Active: 2020-2021
Title: Yuhao Chen: Innovator in Pharmaceutical Crystallography
Introduction
Yuhao Chen is a distinguished inventor based in Suzhou, China, known for his significant contributions to the field of pharmaceutical crystallography. With a total of two patents to his name, Chen has made remarkable strides in the optimization and formulation of drug products, specifically targeting the treatment of prostate cancer.
Latest Patents
Chen's latest patents include innovative developments in crystalline forms of two pharmaceutical compounds. The first patent focuses on the "Crystalline forms of ARN-509, preparation method and use thereof." This disclosure outlines novel crystalline structures of ARN-509, detailing processes for their preparation, pharmaceutical compositions, and their application in creating drug products for androgen receptor antagonists to combat prostate cancer. The improved properties of these forms compared to prior art highlight their potential in future drug optimization and development.
The second patent is for the "Galunisertib crystalline form, preparation method thereof and use thereof." This patent presents a unique crystalline form of Galunisertib, alongside proposed methods of preparation and usage. The pharmaceutical composition that incorporates this crystalline form demonstrates excellent stability, solubility, and hygroscopicity, underscoring its significant value for advancing treatments in various diseases.
Career Highlights
Yuhao Chen currently works at Crystal Pharmaceutical (Suzhou) Co., Ltd., where he has been actively involved in pioneering pharmaceutical research. His innovative approach and mastery in the crystallization processes have positioned him as a valuable asset to the company and the pharmaceutical industry at large.
Collaborations
Throughout his career, Chen has collaborated with esteemed colleagues, including Minhua Chen and Yanfeng Zhang. Their joint efforts have facilitated research initiatives that push the boundaries of drug development and optimization.
Conclusion
In summary, Yuhao Chen's contributions to the field of pharmaceutical crystallography through his patented inventions underscore his role as a key innovator in medicine. His work at Crystal Pharmaceutical is setting new standards for the development of drug formulations that can improve patient outcomes, particularly for those afflicted with prostate cancer. The advancements brought forth by his research hold promise for the future of pharmaceutical sciences.